INTRODUCTION
Beckwitli and hiis associates(l) described the following features of a condition subsequently called the exomplialos-macroglossia-gigantism (E IG) syndrome: macroglossia; omphalocoele; visceromegaly; somatic gigantism and neonatal hlypoglycemia. Combs et al. (2) studied two clhildren with this syndrome and demonstrated that lhyperinsulinism and polycytlhemia during infancy were also part of the syndrome. The facial abnormality was emphasized by Irving (3) . Wiedemann and his co-workers(4,5) and Hooft et al. (6) suggested that the etiology of this syndrome was a nonprogressive ablnormality of the dienceplhalon.
Tlhree studies recently published (7) (8) (9) lhave summarized the information currently available in the literature andl have highliglhted the variability of the syndrome.
The current paper reports studies carried out in eiglht such clhildren, three of wlhom lhad lhypoglycemia. The clhanging nature of their hypoglycemia is documented, and hypoglycemia in the E1\IG syndrome is discussed.
PATIENTS STUDIED
The h-istory and physical findings present at birth in the eight patients are shown in Table 1 . Two of the patients (L.P. and P.R.) were partially discussed in a previous publication (2) . With the exception of D.J., who was one of nonidentical twins, all of the patients were born at term. Three had hypoglycemic seizures. Six of the eight were above the 90th percentile for both height and weiglht. In these six, the measurements of head circumference ranged from the 10th to the 80tlh percentile, thus, frequently giving the appearance of microceplhaly. All eiglht lhad macroglossia, seven lhad midfacial hlypoplasia, five had an abnormal umbilictus, and four were plethoric. As noted in Table 1 , otlher abnormalities were less constant. One patient (T.C.) had a cousin with this syndrome. None of the others had any additional family members known to have this condition.
One patient (S.F.) previously reported as having the ENIG syndrome(2) must now be considered as lhaving idiopathic hypoglycemia, since she neither had macroglossia nor an abnormal umbilicus. Therefore, this patient was not included in the current publication. AVith the exception of G.T. who was Negro, all of the patients were Caucasian and none was retarded.
METHODS
All eiglht children were fasted for periods of 12-24 hr starting at 6 P.1NI. after hiaving eaten a (liet considered normal for the child's age for the 3 previous days ( Table 2 ). Dturing the fast period they were allowed only water to drink. The two children wlho demonstrated hyperinsulinism (D.J. and L.P.) were fasted on several occasions.
Intravenous glucose-tolerance tests were carried out in four patients (Table 3 ).
These tests were cloine at 8-9 A.M. after 12 lhr of fasting and subsequent to at least 3 days of a dliet considered to be normal for the clhild's age. One gram of gltucose per kg body weighit in a 20% solution was administered in 3-5 min.
Venous blood samples were obtained prior to and at 15-min intervals after glucose injection for the first hour and at hourly intervals for the next 5 hr.
Tlhirty micrograms of glucagon (Lilly Glucagon for injection) per kg body weiglht was injected intravenously for the glucagon-tolerance test. Venous blood samples were obtained at 15-min intervals for 1 lhr. This test was performed at the completion of the gltucose-tolerance test in four patients. Glucagon was also administeredl to all eiglht patients at the completion of the 12-to 24-hr fast.
Blood samples were evaluated for glucose, using the glucose oxidase metlhod(10); immunoreactive insulin (IRI), using a double-antibody radioimmunoassay method(ll); and growth hormone (HGH), using a similar radioimmunoassay (12) .
RESULTS
The blood glucose and IRI levels during the 12-to 24-hr periods of fasting are shown in Table 2 . Two patients (D.J. and L.P.) had spontaneous lhypogly-cemia and fasting insulin levels above 40 [U/ml durinig thie first year of life. (Jli our laboratory the average 12-lhr fasting control IRI value for seven chliilrell, 4-16 months of age, is 14.3 ± 2.3 ,U/ml.) Subsequently they lhad hypoglycemia onily wlhen fasted and at that time neitlher of these chliilren lha(l elevated levels of IRI. Hypoglycemia was noted in one otlher patienit (P.R.). Wlhen tested at 2 months of age he developed lhypoglycemia after 20 lhr of fasting; hlowever, IRI was not elevated. The otlher five lhad no symptoms of hypoglycemia andl were able to stustain a 24-lhr fast witlhout cleveloping low blood-glucose levels.
Glucose-and glucagon-tolerance tests are shown in Table 3 . Low bloodgltucose levels were present witlhin 3 hr after glucose administration in four of the five tests. In the fiftlh test (G.T.) blood glucose levels never fell below 56 mg per 100 ml. The previously noted insulin levels above 40 ,uU/ml in D.J. and L.P. are seen here again. Neitlher P.R. nor G.T. lhad elevated IRI levels. HGH concentrations were sliglhtly elevated in the three patients (four tests) in whom it was measured (normal fasting HGH levels are 0-3 ng/ml(13)). However, in each case there was a normal fall in HGH concentrations after glucose administration.
All four patients lhad significantly elevated blood-glucose levels after glucagon administration.
DISCUSSION
Hypoglycemia and associated hyperinsulinism have been noted in the first descriptions of the EMIG syndrome(l,2). Subsequently it has become evident that this is not invariably seen in all such patients. It is Beckwith's current impression that only one third to one half of infants with this syndrome will have neonatal hypoglycemia (7) . Including the current study, approximately 59 such patients hlave been describedI by various authors(l,3,4,6-9,14-18). Since many of these patients lhave not had blood glucose measured, and since in those patients in wlhom this lhas been done, the measurement has been carried out at various ages, it is very (lifficult to give an accurate percentage for the occurrence of hypoglycemia in this syndrome. Nevertlheless, low blood-glucose levels have been documentedt in 10 patients(l,6,9,14,16,18). However, the variability of this finding is seen in the additioinal documenitation of normal blood-glucose concentrations in 15 children with this syndrome(4,6-9). Only two other groups of workers have measured insulin in these children(l,2,18) giving a total of five documented cases of hyperinsulinemia. To these data must be added the significant number of such patients who have had hyperplasia of the Islets of Langerhans. Thirteen of the 22 patients who have come to autopsy have had this finding (3, 7, 8, 9, 15) and althouglh insulin levels were not measuredl, the possibility of hyperinsulinism is (listinct. Despite tlle few data, it wouldI appear that hyperinsulinism is a significant factor in many of tllese patients.
As has been noted above, not all of these patients have hypoglycemia. In adldition, it is likely that not all of these patients with hypoglycemia have hyperinsulinism. In our study one patient (P.R.) had significant hypoglycemia witlhotit hlyperinsulinism at 7 weeks of age. The demonstration of low 10lood glucose in these patients does not warrant the assumption that serum insulini levels ar-e higlh if such measurements are not made.
In the two patients in this study with neonatal hyperinsulinemic hypoglycemia, insulin levels were higlh (tirinig the first year of life. Subsequently, these patients developed low blood glucose values only wlhen fasted for 12-24 hr. This sporadic lhypoglycemia was not associated with elevatedl insulin levels and (lisappeared spontaneously between 3 and 5 years of age.
Mfany of these large newborn infants with marked polycythemia developed into mildlly microceplhalic, nonplethoric clhildlren witlhout the previously noted somatic gigantism. Excess insulin has been shown to be associatedl with polycythemia (19) and to act as an excellent stimulus for growth (20) . Tlhtls, the possibility exists that both the neonatal findings as well as the subsequent clhanges in growtlh pattern can be explained oIn the basis of hyperinsulinism (lurinlg intrauterine, neonatal, and early childlhoodl development.
The responises to glucose administr-ation were variable (Talble 3) and tlherefore difficult to explaiin. Tlhree of the four patients tested (D.J., L.P., and P.R.) developecl hypoglycemia during the gltucose-tolerance tests. Glucose utilization was extremely rapid in D.J. Fifteen miniutes after the glucose injection lher bloodglucose was only 65 mg per 100 ml. L.P., wlhose low blood glucose was first seen 1 hr after glucose administration, may lhave had a reactive or stimulative ratlher than fasting hypoglycemia. P.R. had a blood glucose value of 34 mg per 100 ml 3 hr after glucose administration. Since this value was obtained after 15 hr of fasting, and since this patient had a blood glucose value of 46 mg per 100 ml after 14 hr of fasting on another occasion (Table 2 ) this patient's low blood glucose most likely represents fasting hypoglycemia.
Since there was a significant increase in blood glucose in each patient given glucagon (Table 3 
